Not Yet RecruitingNot Applicable

Ciprofol Versus Propofol in Patients Undergoing Painless Hysteroscopy

188 participantsStarted 2024-08-10

Plain-language summary

Ciprofol exhibits comparable efficacy to that of propofol, and is associated with less injection pain rate, fewer adverse events, higher patient satisfaction, and more stable hemodynamics when used for general anesthesia during the painless hysteroscopy.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age ≥ 18 years old;
✓. undergoing hysteroscopy examination and requiring intravenous anesthesia;
✓. American Society of Anesthesiologists (ASA) physical status I to II;
✓. without communication difficulties, and able to cooperate with intervention implementation;
✓. participating in this trial voluntarily, and signing an informed consent form;

Exclusion criteria

✕. with contraindications for hysteroscopy examination (such as cervical stenosis, difficulty in cervical dilation, reproductive tract infections such as vaginitis and cervicitis) or allergies to the intended anesthetic drugs;
✕. with severe cardiac insufficiency, liver and kidney dysfunction, and other major diseases;
✕. with a history of uterine surgery within the past three months;
✕. body temperature above 37.5 ℃ before the anesthesia;
✕. long-term use of sedative or analgesic drugs.

What they're measuring

Injection pain

Timeframe: 24 hours within hysteroscopy

Trial details

NCT IDNCT06413862

SponsorBaoding First Central Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-09

Contact for this trial

Lei Zhu

+86-13785214850 zhuleizlzl@outlook.com

View on ClinicalTrials.gov More Painless Hysteroscopy trials